- Abbott Laboratories (NYSE:ABT) Q4 results ($M): Total Revenues: 5,188 (-3.1%); Nutrition: 1,800 (-0.2%); Diagnostics: 1,220 (-1.1%); Est. Pharmaceuticals: 885 (-4.0%); Medical Devices: 1,297 (-5.9%).
- Net Income: 767 (-15.2%); EPS: 0.51 (-13.6%); Non-GAAP EPS (continuing ops): 0.62 (0.0%).
- 2016 Guidance: EPS: $1.55 - 1.65; Non-GAAP EPS: $2.10 - 2.20.
- Q1 Guidance: EPS: $0.23 - 0.25; EPS ex-items: $0.38 - 0.40.
- Shares are down 4% premarket on light volume.
Abbott Q4 top line off 3%; net income down 15%; shares off 4% premarket
Recommended For You
About ABT Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ABT | - | - |
Abbott Laboratories |